Biological therapy is opening up a new age for the treatment of cancer. The bacteria -cancer interaction was firstly observed by Busch and Fehleisen (1). To reducing the potential of pathogenicity of using active bacterial, using bacterial products like proteins, enzymes, immune-toxins, that straightaway target malignancy cells and regress the volume of the tumor through expansion inhibition, induction of apoptosis (2). This study was aimed at testing the antiangiogenic bacterial neuraminidase against mammalian adenocarcinoma AN3 transplanted into syngeneic immunocompetent mice through intratumoral injection to determine the antitumor activity in vivo. Histopathological sections for the treated tumor mass demonstrated proliferation of granulation tissue with substantial necrosis region. This study indicated the role of bacterial neuraminidase in reducing the volume of the solid tumor when compared with an untreated group which is a confirmed feature that makes it as anti-tumor agent.
Skip Nav Destination
Article navigation
11 November 2021
2nd International Conference in Physical Science & Advanced Materials: PAM2020
24–27 October 2020
Dubai, United Arab Emirates
Research Article|
November 11 2021
Study the role of bacterial neuraminidase against adenocarcinoma cells in vivo
Shatha M. Ali;
Shatha M. Ali
a
1
Uruk University
, Baghdad, Iraq
aCorresponding author: [email protected]
Search for other works by this author on:
Bahaa A. Laftah;
Bahaa A. Laftah
2
Biology Department, college of Science, University of Baghdad
, Baghdad, Iraq
Search for other works by this author on:
Ahmed M. Al-Shammary;
Ahmed M. Al-Shammary
3
Mustansiriyah University - Iraqi Center for Cancer and Medical Genetics Research
, Baghdad-IRAQ
Search for other works by this author on:
Hasnain S. Salih
Hasnain S. Salih
4
Al-Bayan University
, Baghdad, Iraq
Search for other works by this author on:
aCorresponding author: [email protected]
AIP Conf. Proc. 2372, 030009 (2021)
Citation
Shatha M. Ali, Bahaa A. Laftah, Ahmed M. Al-Shammary, Hasnain S. Salih; Study the role of bacterial neuraminidase against adenocarcinoma cells in vivo. AIP Conf. Proc. 11 November 2021; 2372 (1): 030009. https://doi.org/10.1063/5.0067193
Download citation file:
Pay-Per-View Access
$40.00
Sign In
You could not be signed in. Please check your credentials and make sure you have an active account and try again.
Citing articles via
Inkjet- and flextrail-printing of silicon polymer-based inks for local passivating contacts
Zohreh Kiaee, Andreas Lösel, et al.
Effect of coupling agent type on the self-cleaning and anti-reflective behaviour of advance nanocoating for PV panels application
Taha Tareq Mohammed, Hadia Kadhim Judran, et al.
Design of a 100 MW solar power plant on wetland in Bangladesh
Apu Kowsar, Sumon Chandra Debnath, et al.
Related Content
In vivo oncolytic activity of non-virulent newcastle disease virus Iraqi strain against mouse mammary adenocarcinoma
AIP Conference Proceedings (November 2021)
Immune checkpoint blockade enhances chemophototherapy in a syngeneic pancreatic tumor model
APL Bioeng. (September 2022)
INOSITOL HEXAKISPHOSPHATE MEDIATES APOPTOSIS IN HUMAN BREAST ADENOCARCINOMA MCF‐7 CELL LINE VIA INTRINSIC PATHWAY
AIP Conference Proceedings (April 2010)
Assessment of high-intensity focused ultrasound treatment of rodent mammary tumors using ultrasound backscatter coefficients
J. Acoust. Soc. Am. (August 2013)